Skip to main content

Hartung Michael P's Form 4 filing

Flex Ltd. (FLEX) · filed Nov 25, 2022

Accession no.
0001209191-22-058805
Filed
Nov 25, 2022
Trade date
Nov 23-25, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions. Open-market sales total $76.1K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hartung Michael PCIK 0001820263Officer (Group President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 23, 2022Ordinary SharesSSaleDisposed−1,896$21.00F1−$39,816125,209Direct
Nov 25, 2022Ordinary SharesSSaleDisposed−1,728$21.00F2−$36,288123,481Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Price reflects weighted average sales price; actual sales prices ranged from $21.00 to $21.04. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F2

Price reflects weighted average sales price; actual sales prices ranged from $21.00 to $21.01. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Remarks

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Read the full filing on SEC EDGAR (opens in a new tab)